Section 33-44-01-48 - Standards for microbiological contaminants and mycotoxin compliance testing1. Usable marijuana required to be tested for microbiological contaminants under sections 33-44-01-42, 33-44-01-43, and 33-44-01-44 must be sampled using appropriate aseptic techniques.2. For purposes of the microbiological test, a usable marijuana sample is deemed to have passed if it meets the following standards for microbial and fungal limits in colony forming units per gram (CFU/g): | Concentrates | Medical Cannabinoid Products |
Total viable aerobic bacteria | 104 CFU/g | 105 CFU/g |
Total yeast and mold | 103 CFU/g | 104 CFU/g |
Total coliforms | 102 CFU/g | 103 CFU/g |
Bile-tolerant gram-negative bacteria | 102 CFU/g | 103 C FU/g |
Escherichia coli (pathogenic strains) and salmonella species | Not detected in one gram | Not detected in one gram |
3. For purposes of the mycotoxin test, a usable marijuana sample is deemed to have passed if it meets the following standards:a. The total of aflatoxin B1, B2, G1, and G2 is less than 20 µg/kg of substance; andb. Ochratoxin A is less than 20 µg/kg of substance.4. If the samples do not pass testing standards for microbiological contaminants or mycotoxins, the manufacturing facility shall comply with section 33-44-01-52.N.D. Admin Code 33-44-01-48
Adopted by Administrative Rules Supplement 368, April 2018, effective 4/1/2018.General Authority: NDCC 19-24.1-36
Law Implemented: NDCC 19-24.1-36